Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: SPN041
MIFTS: 51

Spinal Cord Disease

Categories: Neuronal diseases, Bone diseases, Immune diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Spinal Cord Disease

About this section

MalaCards integrated aliases for Spinal Cord Disease:

Name: Spinal Cord Disease 12 15
Spinal Cord Diseases 55 43 44 73
Myelopathy 12 29
Bone Marrow Diseases 73

Classifications:

MalaCards categories:
Anatomical: Neuronal diseases Bone diseases Immune diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:319
ICD9CM 35 336.9
MeSH 44 D013118
NCIt 50 C97110
Sources

Summaries for Spinal Cord Disease

About this section
MedlinePlus : 43 Your spinal cord is a bundle of nerves that runs down the middle of your back. It carries signals back and forth between your body and your brain. It is protected by your vertebrae, which are the bone disks that make up your spine. If you have an accident that damages the vertebrae or other parts of the spine, this can also injure the spinal cord. Other spinal cord problems include Tumors Infections such as meningitis and polio Inflammatory diseases Autoimmune diseases Degenerative diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy Symptoms vary but might include pain, numbness, loss of sensation and muscle weakness. These symptoms can occur around the spinal cord, and also in other areas such as your arms and legs. Treatments often include medicines and surgery.

MalaCards based summary : Spinal Cord Disease, also known as spinal cord diseases, is related to myelitis and central nervous system disease, and has symptoms including back pain, headache and hemiplegia. An important gene associated with Spinal Cord Disease is AQP4 (Aquaporin 4), and among its related pathways/superpathways is Spinal Cord Injury. The drugs Propofol and Sevoflurane have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, bone and brain, and related phenotype is vision/eye.

Wikipedia : 76 The spinal cord is a long, thin, tubular bundle of nervous tissue and support cells that extends from... more...

Sources

Related Diseases for Spinal Cord Disease

About this section

Diseases related to Spinal Cord Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 88)
# Related Disease Score Top Affiliating Genes
1 myelitis 31.6 AQP4 MBP MOG TNF
2 central nervous system disease 30.7 AQP4 CD40LG MBP MOG SOD1 TNF
3 multiple sclerosis 29.1 AQP4 ERVW-1 MBP MOG TNF
4 vascular myelopathy 12.4
5 myelopathy, htlv-1-associated 12.4
6 htlv-1 associated myelopathy/tropical spastic paraparesis 12.3
7 syphilitic myelopathy 12.2
8 retrovirus-associated myelopathy 12.2
9 tropical spastic paraparesis 11.9
10 spondylosis 11.5
11 human t-cell leukemia virus type 1 11.3
12 foix-alajouanine syndrome 11.2
13 tabes dorsalis 11.2
14 neuroschistosomiasis 11.2
15 ossification of the posterior longitudinal ligament of spine 11.1
16 tethered spinal cord syndrome 11.0
17 sneddon syndrome 10.8
18 meningovascular neurosyphilis 10.8 CD40LG MBP
19 post-vaccinal encephalitis 10.8 CD40LG MBP
20 allergic encephalomyelitis 10.8 MBP MOG
21 neonatal myasthenia gravis 10.7 AQP4 SERPINH1
22 parotid disease 10.7 CD40LG HSF4
23 inappropriate adh syndrome 10.7 AQP4 AVPR2
24 trench fever 10.7 CD40LG TNF
25 central pontine myelinolysis 10.7 AQP4 MBP
26 encephalitozoonosis 10.7 CD40LG TNF
27 neuroretinitis 10.7 AQP4 CD40LG MOG
28 miller fisher syndrome 10.6 CD40LG TNF
29 balo concentric sclerosis 10.6 AQP4 MBP MOG
30 acute disseminated encephalomyelitis 10.6 AQP4 MBP MOG
31 internuclear ophthalmoplegia 10.6 AQP4 MBP MOG
32 dysgammaglobulinemia 10.6 CD40LG MBP
33 neuromyelitis optica 10.6 AQP4 MBP MOG
34 louping ill 10.6 CD40LG ERVW-1
35 anterior spinal artery syndrome 10.6 ADAMTS1 MBP
36 kyasanur forest disease 10.6 CD40LG ERVW-1
37 encephalomalacia 10.5 AVPR2 MBP SERPINH1
38 rubella 10.5 CD40LG MOG TNF
39 primary progressive multiple sclerosis 10.5 MBP MOG TNF
40 progressive multifocal leukoencephalopathy 10.5 CD40LG MBP TNF
41 guillain-barre syndrome 10.4 CD40LG MBP TNF
42 optic nerve disease 10.4 AQP4 BTD MBP MOG
43 suppurative otitis media 10.4 CD40LG HSF4
44 secondary progressive multiple sclerosis 10.4 CD40LG HNRNPA1 MBP
45 murray valley encephalitis 10.4 CD40LG ERVW-1
46 transient arthritis 10.3 CD40LG ERVW-1 MBP
47 erysipelas 10.3 SOD1 TNF
48 encephalitis 10.3 AQP4 ERVW-1 MOG
49 optic neuritis 10.3 AQP4 MBP MOG TNF
50 neuritis 10.3 AQP4 MBP MOG TNF

Comorbidity relations with Spinal Cord Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Decubitus Ulcer
Deficiency Anemia Hypertension, Essential
Osteoporosis Paraplegia
Prostate Cancer Spinal Stenosis

Graphical network of the top 20 diseases related to Spinal Cord Disease:



Diseases related to Spinal Cord Disease
Sources

Symptoms & Phenotypes for Spinal Cord Disease

About this section

UMLS symptoms related to Spinal Cord Disease:


back pain, headache, hemiplegia, myoclonus, pain, sciatica, seizures, syncope, tremor, chronic pain, hyperexplexia, vertigo/dizziness, sleeplessness

MGI Mouse Phenotypes related to Spinal Cord Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 vision/eye MP:0005391 9.17 AQP4 BTD HSF4 MBP MOG SOD1
Sources

Drugs & Therapeutics for Spinal Cord Disease

About this section

Drugs for Spinal Cord Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 588)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
2
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
3
Acetylcholine Approved Phase 4,Phase 2,Phase 3,Not Applicable 51-84-3 187
4
Lidocaine Approved, Vet_approved Phase 4,Phase 2 137-58-6 3676
5
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Not Applicable 148553-50-8 5486971
6
Benzocaine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
7
Riluzole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 1744-22-5 5070
8
Citalopram Approved Phase 4,Phase 3,Phase 1,Not Applicable 59729-33-8 2771
9
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-61-6, 62-31-7 681
10
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7439-89-6 23925
11
Menthol Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 2216-51-5 16666
12
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1,Not Applicable 83-43-2 6741
13
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1,Not Applicable 50-24-8 5755
14
Oxybutynin Approved, Investigational Phase 4,Phase 2,Not Applicable 5633-20-5 4634
15
Meloxicam Approved, Vet_approved Phase 4 71125-38-7 5281106 54677470
16
Darifenacin Approved, Investigational Phase 4 133099-04-4 444031
17
Neostigmine Approved, Vet_approved Phase 4,Phase 1,Early Phase 1 59-99-4 4456
18
Tadalafil Approved, Investigational Phase 4,Phase 3 171596-29-5 110635
19
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
20
Oxcarbazepine Approved Phase 4 28721-07-5 34312
21 Piracetam Approved, Investigational Phase 4,Phase 3,Phase 2 7491-74-9
22
Amitriptyline Approved Phase 4 50-48-6 2160
23
Perphenazine Approved Phase 4 58-39-9 4748
24
Zoledronic acid Approved Phase 4,Phase 3,Phase 2 118072-93-8 68740
25
Mexiletine Approved, Investigational Phase 4,Phase 2 31828-71-4 4178
26
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
27
Phenol Approved, Experimental Phase 4 108-95-2 996
28
Norepinephrine Approved Phase 4,Phase 2,Not Applicable 51-41-2 439260
29
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
30
Zinc Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 7440-66-6 23994
31
Zinc sulfate Approved, Investigational Phase 4,Not Applicable 7733-02-0
32
Edetic Acid Approved, Vet_approved Phase 4,Phase 3,Phase 2 60-00-4, 62-33-9 6049
33
Pentetic acid Approved Phase 4,Phase 3,Phase 2 67-43-6
34
Teriparatide Approved, Investigational Phase 4,Phase 2 52232-67-4 16133850
35
Goserelin Approved Phase 4 65807-02-5 47725 5311128
36
Mitoxantrone Approved, Investigational Phase 4 65271-80-9 4212
37
Interferon beta-1a Approved, Investigational Phase 4,Phase 2 145258-61-3 6438354
38
Dextromethorphan Approved Phase 4,Phase 3,Phase 2 125-71-3 5360696 5362449
39
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 93-14-1 3516
40
Cycloserine Approved Phase 4 68-41-7 401 6234
41
Rivaroxaban Approved Phase 4 366789-02-8
42
Denosumab Approved Phase 4 615258-40-7
43
Trazodone Approved, Investigational Phase 4,Phase 2 19794-93-5 5533
44
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
45
Vancomycin Approved Phase 4 1404-90-6 441141 14969
46 tannic acid Approved, Nutraceutical Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
47
Serine Approved, Nutraceutical Phase 4,Phase 1,Phase 2 56-45-1 5951
48
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 59-30-3 6037
49
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 5785 54670067
50
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2 77-92-9 311

Interventional clinical trials:

(show top 50) (show all 1772)
# Name Status NCT ID Phase Drugs
1 Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy Unknown status NCT01052337 Phase 4 anaesthetics: sevofluorane
2 Exoskeletons for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943669 Phase 4
3 Eyegaze Systems for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943656 Phase 4
4 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
5 Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI Unknown status NCT02298660 Phase 4 BOTOX
6 Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain Unknown status NCT01479556 Phase 4 Pregabalin;Placebo
7 A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury Unknown status NCT00725790 Phase 4 Vardenafil;Placebo
8 Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine Unknown status NCT01841671 Phase 4
9 Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis Unknown status NCT00560287 Phase 4
10 Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis Completed NCT00629642 Phase 4 Solifenacin Succinate;Solifenacin Succinate;Oxybutynin Hydrochloride;Placebo
11 Arthroplasty Versus Fusion in Anterior Cervical Surgery: Prospective Study of the Impact on the Adjacent Level Completed NCT00554528 Phase 4
12 Pregabalin and Radicular Pain Study (PARPS) Completed NCT01061697 Phase 4 Pregabalin
13 Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity Completed NCT00800462 Phase 4 Oxybutynin Cl;Trospium Cl;Darifenacin Hydrogen Bromide (HBr)
14 Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage Completed NCT00745095 Phase 4 Neostigmine
15 Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males Completed NCT01067391 Phase 4 tadalafil;placebo
16 Symptom Based Treatment of Neuropathic Pain Completed NCT02180880 Phase 4 Pregabalin and Oxcarbazepine
17 Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels Completed NCT01896037 Phase 4
18 Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients Completed NCT01579500 Phase 4 Botulinum toxin type A;normal saline
19 Pressure Ulcer Healing With Microcyn Completed NCT02001558 Phase 4 Microcyn
20 Assess Efficacy in Subjects With Traumatic Spinal Cord Injury Completed NCT00667966 Phase 4 Vardenafil (Levitra, BAY 38-9456), 10 mg;Placebo;Vardenafil (Levitra, BAY 38-9456), 20 mg
21 A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction Completed NCT00654082 Phase 4 sildenafil;placebo
22 Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia Completed NCT00507546 Phase 4 Ramelteon;Placebo
23 Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury. Completed NCT00320281 Phase 4 botulinum toxin A
24 Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury Completed NCT00286520 Phase 4
25 Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury Completed NCT00252954 Phase 4 Levetiracetam
26 Chronic Pain in Spinal Cord Injury Completed NCT00006428 Phase 4 Amitriptyline
27 Zoledronic Acid Administration in Acute Spinal Cord Injury Completed NCT02042872 Phase 4 Zoledronic acid
28 Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine Completed NCT02643368 Phase 4
29 Mexiletine for the Treatment of Muscle Cramps in ALS Completed NCT01811355 Phase 4 Mexiletine;Placebo
30 A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania Completed NCT02582255 Phase 4
31 A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age Completed NCT02580201 Phase 4
32 Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrixâ„¢ During Pregnancy or Immediately Post-delivery Completed NCT02422264 Phase 4 Prevnar13
33 Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules Completed NCT02412514 Phase 4
34 Myobloc Atrophy Study Completed NCT02052024 Phase 4 Botox;MYOBLOC
35 Polio End-game Strategies - Poliovirus Type 2 Challenge Study Completed NCT02189811 Phase 4
36 Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan Completed NCT02005536 Phase 4
37 Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS) Completed NCT00613899 Phase 4
38 IPV Clinical Trial - The Gambia Completed NCT01847872 Phase 4 IPV IM Needle;IPV ID Needle;IPV IM Device;IPV ID Device
39 Project to Improve Symptoms and Mood in People With Spinal Cord Injury Completed NCT00592384 Phase 4 venlafaxine XR;placebo
40 Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine Completed NCT01831050 Phase 4
41 CARE Canadian ALS Riluzole Evaluation Completed NCT00542412 Phase 4 Riluzole
42 An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia Completed NCT01716221 Phase 4 bupropion & Citalopram;Bupropion & Placebo;Placebo & Citalopram;Placebo & Placebo
43 IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi. Completed NCT01695798 Phase 4
44 Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines Completed NCT01616693 Phase 4
45 Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE Completed NCT01546909 Phase 4
46 Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine Completed NCT01475539 Phase 4
47 Comparison of Immunogenicity and Reactogenicity of INFANRIXâ„¢ HEXA and HEXAVACâ„¢ Vaccines as a Primary Vaccination Course Completed NCT01457547 Phase 4
48 Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI) Completed NCT00826228 Phase 4 teriparatide
49 Regulatory Post-Marketing Surveillance Study for TETRAXIMâ„¢ Completed NCT01437423 Phase 4
50 Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexaâ„¢ or Infanrix-IPV/Hibâ„¢ Completed NCT01358825 Phase 4

Search NIH Clinical Center for Spinal Cord Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: spinal cord diseases

Sources

Genetic Tests for Spinal Cord Disease

About this section

Genetic tests related to Spinal Cord Disease:

# Genetic test Affiliating Genes
1 Myelopathy 29
Sources

Anatomical Context for Spinal Cord Disease

About this section

MalaCards organs/tissues related to Spinal Cord Disease:

41
Spinal Cord, Bone, Brain, Testes, Bone Marrow, Skin, Medulla Oblongata
Sources

Publications for Spinal Cord Disease

About this section

Articles related to Spinal Cord Disease:

(show top 50) (show all 82)
# Title Authors Year
1
Agreement between transverse T2-weighted and three-dimensional constructive interference in steady state sequences in the evaluation of spinal cord disease in dogs. ( 29540556 )
2018
2
HIV and spinal cord disease. ( 29604979 )
2018
3
Primary central nervous system lymphoma of T-cell origin: an unusual cause of spinal cord disease. ( 27878765 )
2016
4
Prevalence, clinical presentation, prognosis, and outcome of 17 dogs with spinal shock and acute thoracolumbar spinal cord disease. ( 26676985 )
2016
5
The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model. ( 25542977 )
2015
6
[Novel aspects of diagnostics and therapy of spinal cord diseases]. ( 25001239 )
2014
7
Autonomic rectal dysfunction in patients with multiple sclerosis and bowel symptoms is secondary to spinal cord disease. ( 24608309 )
2014
8
Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. ( 25224602 )
2014
9
Depression and pain among inpatients with spinal cord injury and spinal cord disease: differences in symptoms and neurological function. ( 23072715 )
2013
10
STIR muscle hyperintensity in the cervical muscles associated with inflammatory spinal cord disease of unknown origin. ( 23458643 )
2013
11
Positron emission tomography in spinal cord disease. ( 24182699 )
2013
12
Low serum vitamin D levels and recurrent inflammatory spinal cord disease. ( 22083799 )
2012
13
Spinal cord disease in patients with cancer. ( 22810129 )
2012
14
Stress, internal resources and functioning in a person with spinal cord disease. ( 22430577 )
2012
15
Anorectal function and the effect of biofeedback therapy in ambulatory spinal cord disease patients having constipation. ( 20602567 )
2010
16
Clinical and magnetic resonance imaging findings in 92 cats with clinical signs of spinal cord disease. ( 18602328 )
2009
17
Surgical management of pressure ulcers during inpatient neurologic rehabilitation: outcomes for patients with spinal cord disease. ( 19569459 )
2009
18
Characterization of spatiotemporal gait characteristics in clinically normal dogs and dogs with spinal cord disease. ( 19951114 )
2009
19
Profound biotinidase deficiency in a child with predominantly spinal cord disease. ( 18645204 )
2008
20
Rehabilitation outcomes after infection-related spinal cord disease: a retrospective analysis. ( 18356619 )
2008
21
Signs of spinal cord disease in two heifers caused by Listeria monocytogenes. ( 14758832 )
2004
22
Spinal cord disease in West Nile virus infection. ( 12575663 )
2003
23
From the electrodiagnosis lab...H-reflexes in hand muscles after cervical spinal cord disease. ( 14598812 )
2003
24
Spinal cord disease in West Nile virus infection. ( 12571269 )
2003
25
[An autopsy case with subacute spinal cord disease showing progressive paraplegia]. ( 12166108 )
2002
26
Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease. ( 12121731 )
2002
27
Electrophysiological evaluation of root and spinal cord disease. ( 12524565 )
2002
28
The use of magnetic motor evoked potentials in horses with cervical spinal cord disease. ( 11902758 )
2002
29
Correlation between severity of clinical signs and motor evoked potentials after transcranial magnetic stimulation in large-breed dogs with cervical spinal cord disease. ( 12420825 )
2002
30
Dysfunctional elimination syndrome in children without obvious spinal cord diseases. ( 11732126 )
2001
31
Intrathecal baclofen therapy for spinal origin spasticity: spinal cord injury, spinal cord disease, and multiple sclerosis. ( 22151114 )
1999
32
Spinal cord disease due to melioidosis. ( 10450444 )
1999
33
Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. ( 9494997 )
1998
34
The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. ( 9494998 )
1998
35
Vertebrospinal angiography in the evaluation of vertebral and spinal cord disease. ( 8873094 )
1996
36
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. ( 8649545 )
1996
37
Spinal cord disease due to vacuolar myelopathy in AIDS. ( 8039791 )
1994
38
[Ophthalmologic manifestations in spinal cord diseases caused by HTLV-I virus. Clinical study of 30 cases]. ( 8083490 )
1994
39
Spontaneous ejaculation secondary to spinal cord disease. ( 8164008 )
1994
40
Somatosensory potentials in dogs with naturally acquired thoracolumbar spinal cord disease. ( 8291776 )
1993
41
The diagnostic impact of magnetic resonance imaging on the evaluation of suspected spinal cord disease. ( 1441553 )
1992
42
Management of bowel dysfunction in children with spinal cord disease or injury by means of the enema continence catheter. ( 1735813 )
1992
43
Congenital, hereditary and developmental spinal cord disease. ( 1325226 )
1992
44
Repair and regeneration: experimental aspects of spinal cord disease. ( 1515695 )
1992
45
Medical complications of spinal cord disease. ( 1921958 )
1991
46
Disturbed sexual function in patients with spinal cord disease. ( 1921957 )
1991
47
Rehabilitation of patients with spinal cord disease. ( 1921954 )
1991
48
Disorders of bladder function in spinal cord disease. ( 1921955 )
1991
49
Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study. ( 2234312 )
1990
50
Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease. ( 2468107 )
1988
Sources

Variations for Spinal Cord Disease

About this section
Sources

Expression for Spinal Cord Disease

About this section
Search GEO for disease gene expression data for Spinal Cord Disease.
Sources

Pathways for Spinal Cord Disease

About this section

Pathways related to Spinal Cord Disease according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Spinal Cord Injury 1
10.88 AQP4 MBP TNF
Sources

GO Terms for Spinal Cord Disease

About this section

Cellular components related to Spinal Cord Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.92 AQP4 CD40LG MOG TNF

Biological processes related to Spinal Cord Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 membrane organization GO:0061024 9.33 AMPH AVPR2 MBP
2 central nervous system development GO:0007417 9.13 BTD MBP MOG
3 regulation of immunoglobulin secretion GO:0051023 8.62 CD40LG TNF
Sources

Sources for Spinal Cord Disease

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....